Zota Health Care's Q3 FY 2025-26 Quarterly Results
- 05 Feb 2026
Result Summary
- Zota Health Care Ltd reported a 10.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 99.2%.
- Its expenses for the quarter were up by 17.7% QoQ and 87.3% YoY.
- The net profit increased 83.1% QoQ and increased 56.5% YoY.
- The earnings per share (EPS) of Zota Health Care Ltd declined at 9.21 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 144.67 | 130.58 | 72.63 | 10.8% | 99.2% |
Total Expenses | 170.62 | 144.97 | 91.11 | 17.7% | 87.3% |
Profit Before Tax | -25.95 | -14.38 | -18.48 | 80.5% | 40.4% |
Tax | 3.69 | 1.81 | 0.46 | 103.9% | 702.2% |
Profit After Tax | -29.64 | -16.19 | -18.94 | 83.1% | 56.5% |
Earnings Per Share | -9.21 | -5.02 | -6.31 | 83.5% | 46.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Zota Health Care Ltd is an Indian pharmaceutical company engaged in the development and manufacturing of a wide range of pharmaceutical products. The company operates in the healthcare sector, primarily focusing on the production and distribution of formulations, herbal products, and nutraceuticals. These products are typically distributed under various brand names and are available both domestically and in international markets. Zota Health Care Ltd is known for its innovation in the healthcare industry, consistently working to expand its product offerings to meet the diverse needs of consumers. As of the latest data available up to October 2023, no specific recent major developments have been identified for Zota Health Care Ltd.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Zota Health Care Ltd reported a total income of ₹144.67 crores. This represents an increase of 10.8% compared to the previous quarter (Q2FY26), where the total income was ₹130.58 crores. On a year-over-year basis, the company showed a significant growth in total income, with a 99.2% increase from Q3FY25, when the total income was ₹72.63 crores. These figures reflect the company's ability to enhance its revenue generation over both the short and longer-term periods covered in the data.
Profitability
Despite the increase in total income, Zota Health Care Ltd reported a loss before tax of ₹25.95 crores in Q3FY26, which is a deterioration from the ₹14.38 crores loss recorded in Q2FY26, marking an 80.5% increase in losses quarter-over-quarter. Furthermore, the loss before tax grew by 40.4% year-over-year from Q3FY25’s figure of ₹18.48 crores. After accounting for taxes, the profit after tax stood at a loss of ₹29.64 crores in Q3FY26, compared to a loss of ₹16.19 crores in Q2FY26, showing an 83.1% increase in losses QoQ. Year-over-year, the loss after tax increased by 56.5% from a loss of ₹18.94 crores in Q3FY25. The earnings per share also reflected these changes, with a value of ₹-9.21 in Q3FY26, compared to ₹-5.02 in Q2FY26 and ₹-6.31 in Q3FY25.
Operating Metrics
Zota Health Care Ltd’s total expenses in Q3FY26 amounted to ₹170.62 crores, which is a 17.7% increase from the previous quarter (Q2FY26) where expenses were ₹144.97 crores. Year-over-year, total expenses rose by 87.3% from ₹91.11 crores in Q3FY25. The tax expense for Q3FY26 was ₹3.69 crores, marking a significant increase of 103.9% from the previous quarter's tax expense of ₹1.81 crores and a 702.2% increase from the tax expense of ₹0.46 crores in Q3FY25. These metrics illustrate the company's cost structure and tax implications over the periods analyzed, highlighting the financial dynamics impacting its operations.